Back to search
Henoch Schönlein Purpura
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Henoch Schönlein Purpura trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Henoch Schönlein Purpura trials you may qualify forThe primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy follow…
Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with…
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online…
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of…
Henoch-Schönlein purpura nephritis (HSPN) is the most common secondary glomerular disease in children. About 40% of HSPN cases are accompanied by mild proteinur…
IgA vasculitis is relatively common in children,especially in Asian countries. Abdominal manifestation could be severe, including bleeding, pancreatitis,appendi…
The primary objective of this study is to search for evidence of quantitative or functional defects in plasma regulatory T cells (Tregs) in pediatric patients w…
The study aims to explore the therapeutic value and mechanism of Interleukin-2 on children with Henoch-schönlein purpura.
About 20% children with allergic purpura develop nephritis syndrome or nephrotic syndrome, 1% to 7% to kidney failure or end-stage renal disease. Children with…